Christopher J Edwards
Overview
Explore the profile of Christopher J Edwards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
2329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edwards C, Erstad B, Ng V
Am J Health Syst Pharm
. 2025 Mar;
PMID: 40036668
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are...
2.
Goldstein E, Neuman M, Haar V, Li A, Guerra-Londono C, Elwyn G, et al.
Br J Anaesth
. 2025 Feb;
PMID: 39933964
Background: Shared decision making is rarely used in anaesthesia consultations. Because either spinal or general anaesthesia can be appropriate for many patients undergoing surgery to repair a hip fracture, this...
3.
Edwards C, Kronke G, Avouac J, Li Z, Conti F, Balsa A, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814441
Objective: This study examined the effect of dose step-down in patients with rheumatoid arthritis (RA) who achieved sustained disease control with baricitinib 4 mg once daily for up to 96...
4.
Mahmoud K, Md Yusof M, Teh L, Khan S, Yee C, DCruz D, et al.
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39700424
Objective: To propose a new definition for SLEDAI arthritis informed by imaging. Methods: We performed a planned secondary analysis of observational data from a multicentre study evaluating SLE patients with...
5.
Spinner C, Bell S, Einsele H, Tremblay C, Goldman M, Chagla Z, et al.
Adv Ther
. 2024 Dec;
42(2):666-719.
PMID: 39680311
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact. The emergence of several variants during the pandemic has presented...
6.
Ceobanu G, Edwards C
Lupus
. 2024 Oct;
33(13):1403-1415.
PMID: 39383302
Systemic lupus erythematosus (SLE) is a complex multi-organ autoimmune disease marked by the production of autoantibodies against nuclear structures, formation of immune complexes, and chronic inflammation triggered by their tissular...
7.
Ramakrishna C, Mason A, Edwards C
Autoimmun Rev
. 2024 Sep;
23(11):103649.
PMID: 39349269
Tyk2 is a member of the JAK kinase family. It is an important mediator in pro-inflammatory signalling, implicated in both innate and adaptive immune system. Activation of Tyk2 is believed...
8.
Buch M, Walker D, Edwards C, Barry J, Akroyd L, Ekoka Omoruyi E, et al.
Rheumatology (Oxford)
. 2024 Sep;
PMID: 39331638
Objectives: Clinical trials restricted to moderately active RA are limited. Filgotinib is approved for treating moderate to severe active RA. This post hoc analysis assessed efficacy and safety of filgotinib...
9.
Kingsbury S, Tharmanathan P, Keding A, Watt F, Scott D, Roddy E, et al.
Ann Intern Med
. 2024 Jul;
177(9):1145-1156.
PMID: 39074374
Background: Treatments for osteoarthritis (OA) are limited. Previous small studies suggest that the antirheumatic drug methotrexate may be a potential treatment for OA pain. Objective: To assess symptomatic benefits of...
10.
Marr C, McDowell B, Holmes C, Edwards C, Cardwell C, McHenry M, et al.
J Alzheimers Dis
. 2024 Apr;
99(1):161-175.
PMID: 38669538
Background: Evidence suggests that TNF inhibitors (TNFi) used to treat rheumatoid arthritis (RA) may protect against Alzheimer's disease progression by reducing inflammation. Objective: To investigate whether RA patients with mild...